It has been estimated that human immunodeficiency virus type 1 originated from the zoonotic transmission of simian immunodeficiency virus (SIV) of chimpanzees, SIVcpz, and that SIVcpz emerged by the recombination of two lineages of SIVs in Old World monkeys (SIVgsn/mon/mus in guenons and SIVrcm in red-capped mangabeys) and SIVcpz Nef is most closely related to SIVrcm Nef. These observations suggest that SIVrcm Nef had an advantage over SIVgsn/mon/mus during the evolution of SIVcpz in chimpanzees, although this advantage remains uncertain. Nef is a multifunctional protein which downregulates CD4 and coreceptor proteins from the surface of infected cells, presumably to limit superinfection. To assess the possibility that SIVrcm Nef was selected by its superior ability to downregulate viral entry receptors in chimpanzees, we compared its ability to down-modulate viral receptor proteins from humans, chimpanzees and red-capped mangabeys with Nef proteins from eight other different strains of SIVs. Surprisingly, the ability of SIVrcm Nef to downregulate CCR5, CCR2B and CXCR6 was comparable to or lower than SIVgsn/mon/mus Nef, indicating that ability to down-modulate chemokine receptors was not the selective pressure. However, SIVrcm Nef significantly downregulates chimpanzee CD4 over SIVgsn/mon/mus Nefs. Our findings suggest the possibility that the selection of SIVrcm Nef by ancestral SIVcpz is due to its superior capacity to down-modulate chimpanzees CD4 rather than coreceptor proteins.
INTRODUCTION
Previous studies have provided evidence suggesting that human immunodeficiency virus type 1 (HIV-1), the causative agent of AIDS in humans, emerged from zoonotic transmission of simian immunodeficiency virus (SIV) in chimpanzees, SIVcpz (Gao et al., 1999; Keele et al., 2006) . In addition, phylogenetic analyses estimated that SIVcpz emerged by the recombination of two lineages of SIVs in Old World monkeys: SIVgsn/mon/mus in guenons (e.g. greater spot-nosed monkey, mona monkey and mustached monkey) and SIVrcm in red-capped mangabeys (Bailes et al., 2003; Sharp & Hahn, 2010) . In terms of accessory proteins, SIVcpz shares the Vpu gene of SIVgsn/mon/ mus, but the Nef gene is most closely related to that of SIVrcm (Bailes et al., 2003; Sharp & Hahn, 2010; Sharp et al., 2005) . This selection suggests that there must be some biological advantage conferred by this particular Nef gene over that from SIVgsn/mon/mus.
It is well known that Nef is a pluripotent protein. For instance, Nef potently enhances the infectivity of nascent virions (Goldsmith et al., 1995; Pizzato et al., 2007) .
In addition, Nef induces the activation of cellular protein kinases such as p21 protein-activated kinase 2 and haematopoietic cell kinase (Olivieri et al., 2011; Trible et al., 2006) . Furthermore, Nef downregulates CD4, the primary receptor for primate lentiviruses, and coreceptors from the surface of infected cells to evade superinfection (Berger et al., 1999; Goldsmith et al., 1995; Hrecka et al., 2005; Landi et al., 2011; Michel et al., 2005) . As the coreceptors for viral infection, HIV-1 (Choe et al., 1996; Deng et al., 1996; Dragic et al., 1996) and SIVcpz (Li et al., 2012; Van Heuverswyn et al., 2007) mainly use CCR5, whilst SIVrcm mainly uses CCR2B and CXCR6 (also known as BONZO, STRL33 and CD186) instead of CCR5 because it has deletions that render it inactive (Beer et al., 2001; Chen et al., 1998) . However, the coreceptor usage of SIVgsn/mon/mus is still unclear due to lack of the infectious reagents necessary to conduct these studies (Courgnaud et al., 2003 (Courgnaud et al., , 2002 ).
As described above, one of the major roles of Nef is to downregulate CD4 and coreceptors from the surface of infected cells. As a broad spectrum of viruses downmodulate receptor molecules from the surface of infected cells to evade superinfection (Diepolder, 2009; Hunter, 1997; Nethe et al., 2005) , the efficient downregulation of receptor proteins can be critical for viral replication and spread. Therefore, these insights raise the possibility that ancestral SIVcpz selected SIVrcm Nef instead of SIVgsn/ mon/mus Nef, as the ability of SIVrcm Nef to downmodulate receptor/coreceptor proteins is superior to those of SIVgsn/mon/mus Nef proteins. To address this hypothesis, here we investigated the downregulation efficacy of CD4 and coreceptors (CCR5, CCR2B and CXCR6) by Nef proteins of HIV-1, SIVcpz, SIVrcm, SIVgsn, SIVmon and SIVmus. Although previous studies analysed the ability of HIV-1 and certain SIV Nef proteins to downregulate several transmembrane proteins, including CD4 and coreceptors Michel et al., 2005; Venzke et al., 2006) , these analyses were performed using human receptor proteins, and Nef's activity to down-modulate the receptor proteins of chimpanzees and Old World monkeys has not been evaluated. In this study, we newly determined three sequences: the cytoplasmic tails of red-capped mangabey CD4, CCR2B and CXCR6. As Nef is a cytoplasmic protein and can downregulate receptor proteins by targeting their cytoplasmic tails, we construct the expression plasmids for the chimeric receptor proteins possessing the cytoplasmic tail of chimpanzees or red-capped mangabeys. As the extracellular domains of these chimeric proteins are identical to those of human origin, we are able to assess the surface expression levels of these chimeric proteins by using the antibody targeting human proteins. By utilizing this experimental system, we directly investigated the susceptibility of these receptor proteins to Nef-mediated downregulation.
RESULTS

Phylogeny of HIV-1/SIV Nef
To address the evolutionary event at the emergence of SIVcpz, particularly on the origin of SIVcpz Nef, we set out to perform phylogenetic analysis on HIV-1/SIV Nef proteins. In this analysis we used the sequences of two HIV-1 (strains NL4-3 and JRCSF), two SIVcpz (strains MB897 and EK505), three SIVrcm (strains 02CM8081, GAB1 and NG411), two SIVgsn (strains 99CM71 and 99CM166), two SIVmon (strains NG1 and 99CMCML1) and two SIVmus (strains 01CM1085 and 01CM1239) (Fig. 1a) . Corresponding to the previous observations (Bailes et al., 2003; Sharp & Hahn, 2010; Sharp et al., 2005) , our result suggested that SIVcpz Nef was closely Amino acid similarity of HIV-1/SIV Nef. The percentage similarity of the amino acid sequence of Nef used in this study was analysed using GENETYX v 9.0 and is summarized.
related to SIVrcm Nef rather than SIVgsn/mon/mus Nefs, and that SIVcpz Nef originated from SIVrcm Nef. However, the similarity of SIVrcm Nef to SIVcpz Nef was *80 % (Fig. 1b) , which suggested further acquisition of mutations occurred since the emergence of SIVcpz.
Downregulation of CD4 and coreceptors by HIV-1/ SIV Nef proteins
To directly assess the Nef-mediated downregulation of receptor proteins including CD4, CCR5, CCR2B and CXCR6 of humans, chimpanzees and red-capped mangabeys, we obtained sequence information from GenBank ( Table 1) . As certain red-capped mangabey sequences have not been reported as yet, we determined the sequences of the cytoplasmic tails of red-capped mangabey CD4, CCR2B and CXCR6. The amino acid alignments of CD4, CCR5, CCR2B and CXCR6 are shown in Figs 2(a), 3(a), 4(a) and 5(a), respectively. Based on these sequences, we then constructed plasmids expressing the chimeric proteins of human receptors possessing the cytoplasmic tails of chimpanzees or red-capped mangabeys. As Nef is a cytoplasmic protein, the cytoplasmic tails of transmembrane proteins can be targeted by Nef for their downregulation. In addition, we are able to detect the surface expression of these chimeric proteins by using the antibody targeting human proteins because the extracellular domains of these chimeric proteins were identical to those of human origin.
By using this system, we first analysed the level of Nefmediated downregulation of CD4. As shown in Fig. 2(a) , an amino acid difference was detected in the cytoplasmic tail of chimpanzees and red-capped mangabeys compared with that of humans (E430Q). Corresponding to previous reports (Goldsmith et al., 1995; Landi et al., 2011) , human CD4 was significantly downregulated by the Nef proteins of HIV-1 (strain JRCSF) and SIVcpz (strain MB897) (Fig. 2c) . However, although five Nef proteins of SIVgsn/mon/mus (strains 99CM166, NG1, 99CMCML1, 01CM1085 and 01CM1239) significantly downregulated human CD4, three Nef proteins of SIVrcm (strains GAB1, NG411 and 02CM8081) did not (Fig. 2c) . Although the molecular mass and expression level of the Nef proteins differed from each other, the transfection efficacy was comparable because the expression level of GFP was similar (Fig. 2b, d ).
We then analysed the surface expression level of the chimeric CD4 possessing the cytoplasmic tails of chimpanzees and red-capped mangabeys. In contrast to the results for human CD4 (Fig. 2c) , CD4 with chimpanzee/red-capped mangabey cytoplasmic tails could be downregulated by HIV-1 Nef and SIVcpz Nef, but not by SIVgsn/mon/mus Nefs. Moreover, it was of particular interest that the surface expression level of CD4 with chimpanzee/red-capped mangabeys cytoplasmic tails in the cells expressing SIVrcm Nef proteins was significantly lower than that of the cells expressing SIVgsn/mon/mus proteins with a statistically significant difference ( Fig. 2e ; P50.010 by Student's t-test). These results suggested that the ability of SIVrcm Nef to downregulate chimpanzee CD4 is superior to that of SIVgsn/mon/mus Nef.
Next, we investigated the efficacy of Nef-mediated downregulation of CCR5. As shown in Fig. 3 (a), an amino acid change was detected in the cytoplasmic tail of red-capped mangabey CCR5 when compared with those with human and chimpanzee CCR5 (P332S; Fig. 3a ).
We also found that all Nef proteins except for the Nef of SIVmus (01CM1085) significantly downregulated human CCR5 (Fig. 3c) . However, the downregulation of the chimeric CCR5 possessing the cytoplasmic tail of red-capped mangabeys was not observed with the Nefs of HIV-1, SIVcpz, SIVrcm NG411 and SIVmus 01CM1085, but was remarkable with the Nefs of SIVgsn/mon/mus other than SIVmus 01CM1085 (Fig. 3e) . We confirmed that all Nef proteins were well expressed ( Fig. 3b, d ).
Fig. 4(a) describes an amino acid change on the cytoplasmic tail of CCR2B between humans and chimpanzees (V343A). In addition, by analysing the sequence of the cytoplasmic tail of red-capped mangabey CCR2B, we revealed that the cytoplasmic tail of red-capped mangabey CCR2B is highly diversified compared with the cases of CD4 and CCR5, and the five amino acids positioned at 318, 323, 343, 352 and 358 of red-capped mangabey CCR2B were different from those of chimpanzee CCR2B (Fig. 4a) . However, as shown in Fig. 4 (b, g), the Nef proteins of SIVgsn/mon/mus significantly downregulated CCR2B regardless of its host species, and the downregulation ability of the Nef proteins of HIV-1, SIVcpz and SIVrcm on CCR2B was relatively poor or none. Finally, we determined the sequence of the cytoplasmic tail of red-capped mangabey CXCR6 and revealed that the cytoplasmic tails of human, chimpanzee and red-capped mangabey CXCR6 were identical (Fig. 5a ). Also, in contrast to the case of chimpanzee/red-capped mangabey cytoplasmic tails (Fig. 2e ), Old World monkey Nef proteins significantly downregulated CXCR6, whilst HIV-1 and SIVcpz Nefs did not (Fig. 5b, c ).
Downregulation ability of HIV-1/SIV Nef proteins
Based on these analyses, we summarized the downregulation ability of Nef proteins from 10 different HIV-1/SIV strains analysed as radar charts (Fig. 6 ). By summarizing these results, we found that the downregulation ability of SIVgsn/mon/mus Nef proteins was significantly higher than that of SIVrcm Nef, except for chimpanzee CD4 (Fig. 6 ). Taken together, these findings indicated that although SIVgsn/mon/mus Nefs were able to downregulate coreceptors more efficiently than SIVrcm Nefs, the ancestor of SIVcpz selected SIVrcm Nef for its superior capacity to downregulate chimpanzee CD4.
DISCUSSION
In this study, we particularly focused on the role of SIV Nef proteins in down-modulating receptors and coreceptors for HIV-1/SIV infection. Although previous studies used only human receptor proteins to evaluate Nef's effect Michel et al., 2005; Venzke et al., 2006) , here we newly identified the sequences of cytoplasmic tails of red-capped mangabey CD4, CCR2B and CXCR6, and directly evaluated the downregulation efficacy of Nef proteins including one HIV-1, one SIVcpz, three SIVrcm, one SIVgsn, two SIVmon and two SIVmus. Our results suggest that the ability of SIVrcm Nef to downregulate chemokine receptors, including CCR5 (Fig. 3) , CCR2B (Fig. 4) and CXCR6 (Fig. 5) , is comparable to or generally lower than those of SIVgsn/ mon/mus Nef proteins regardless of their host species. However, the surface level of chimpanzee CD4 of SIVrcm Nef-expressing cells was significantly lower than that of cells expressing SIVgsn/mon/mus Nefs (Fig. 2e) . Although the magnitude of SIVrcm Nef on chimpanzee CD4 was moderate, this may have been advantageous to the SIVcpz ancestor. Acquisition of certain mutations to SIVrcm Nef may drastically enhance the downregulation ability in chimpanzees, as with contemporary SIVcpz Nef.
In contrast to our working hypothesis, the downregulation ability of SIVrcm Nef on CCR5 (Fig. 3) , CCR2B (Fig. 4) and CXCR6 (Fig. 5) is comparable to or even lower than those of SIVgsn/mon/mus Nef proteins. In addition, this tendency was not due to the difference of the cytoplasmic tails of host species (Figs 2-5) . Moreover, the overall downregulation ability of SIVgsn/mon/mus Nef was significantly higher than that of SIVrcm Nef (Fig. 6) . These results suggest that SIVgsn/mon/mus Nef proteins potently down-modulate various transmembrane proteins, including chemokine receptors. In this regard, it is well known that chemokine receptors play crucial roles for leukocytes, including CD4 + T-cells, in migrating and moving in the individual body (Moser et al., 2004; Pease & Williams, 2006; Rollins, 1997) . As chemokine signalling is highly organized and regulated in vivo, aberrant down-modulation by Nef may be harmful. It has been assumed that Nef and other viral factors, such as Env and Vpu, downregulate CD4 and coreceptors to avoid the risk of superinfection Glushakova et al., 2001; Lundquist et al., 2002) . Taken together with our findings, it is plausible that the down-modulation activity of SIVgsn/mon/mus Nef proteins was too drastic and even toxic to be selected by ancestral SIVcpz. Furthermore, these findings are reminiscent of the 'less-is-more' hypothesis: losing certain function(s) can be advantageous if possessing certain other function(s) is the cost during the evolutionary process (D'Souza et al., 2014; Olson, 1999) . In other words, ancestral SIVcpz might be 'negatively' selected SIVrcm Nef because the exclusion of potently toxic protein, SIVgsn/mon/mus Nef, has been more crucial for ancestral SIVcpz than the avoidance of superinfection.
Although there is only one amino acid change between the cytoplasmic tails of human CD4 and those of chimpanzee/ red-capped mangabey CD4 (E430Q; Fig. 2a) , it was surprising that the chimeric CD4 molecule possessing the cytoplasmic tail of chimpanzees/red-capped mangabeys
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is clearly downregulated by only HIV-1 and SIVcpz Nefs (Fig. 2e) . As shown in Fig. 2(a) , the polymorphic residue is located at the proximal region associated with Nef-mediated downregulation (Grzesiek et al., 1996) . Therefore, this amino acid substitution may affect the conformation of CD4, resulting in alteration of CD4-Nef complex formation (Grzesiek et al., 1996; Preusser et al., 2001) . Moreover, there is another possibility that the interaction of Nef with cellular proteins other than receptor proteins may be important for receptor downregulation. In fact, it has been reported that Nef interacts with cellular adaptor protein 2, which plays a crucial role in the trafficking of membrane proteins from the plasma membrane to endosome compartments (Traub, 2009) , resulting in down-modulation of receptor proteins (Lindwasser et al., 2008; Ren et al., 2014) . Furthermore, the cellular interactants between apes and guenons may differ from each other, which may influence receptor down-modulation by Nef. In addition, the results obtained by utilizing human proteins do not always correspond with those from utilizing the proteins of apes and monkeys, and further highlight the importance of the re-evaluation of cellular proteins of apes and monkeys if necessary.
In addition to CD4 and chemokine receptors, it has been reported that SIV Nef potently down-modulates tetherin (Jia et al., 2009; Sauter et al., 2009; Zhang et al., 2009) . In particular, chimpanzee tetherin can be antagonized by SIVcpz Nef (Sauter et al., 2009) . This raises the possibility that SIVrcm Nef has been selected because the antagonizing activity of SIVrcm Nef against chimpanzee tetherin is higher than Nefs of SIVgsn/mon/mus. However, we have recently revealed that the anti-chimpanzee tetherin activity of SIVrcm Nef is comparable to those of SIVgsn/mon/mus Nefs . These observations suggest that Nef's ability to down-modulate chimpanzee tetherin is not associated with the selection of SIVrcm Nef by SIVcpz. In addition to the multiple roles of Nef described in the Introduction, it has been reported that Nef potently downregulates MHC class I (Landi et al., 2011; Schwartz et al., 1996) and CD28 (Swigut et al., 2001) , but upregulates CD74, the invariant chain of MHC class II (Keppler et al., 2006; Stumptner-Cuvelette et al., 2001) . Furthermore, a recent study revealed that Nef potently downregulates a broad range of cellular transmembrane proteins from the cell surface (Haller et al., 2014) . Therefore, Nef's ability, other than the down-modulation of coreceptors and tetherin, may be associated with the ancestral SIVcpz's choice; further investigations will be needed to clarify this issue. 
METHODS
Ethics statement. To determine the sequences of CD4, CCR2B and CXCR6, blood was collected from six wild-caught red-capped mangabeys in Nigeria according to the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) under a National Institute of Allergy and Infectious Diseases Animal Care and Use Committee-approved protocol (Beer et al., 2001; Vinton et al., 2011) .
Sequencing PCR. Red-capped mangabey genomic DNA was isolated from cryopreserved PBMCs (Beer et al., 2001; Vinton et al., 2011) , and PCR was performed by using Platinum Taq DNA Polymerase High Fidelity (Life Technologies) and the following primers: CD4CT-F#2 (59-AGGAGGGTGGTGCACTGA-39) and CD4CT-R2 (59-TGGGGA-GGCTGCAATTGG-39) for the cytoplasmic tail region of red-capped mangabey CD4; CXCR6-F (59-GGAATGTGCTTAGGGGTCAG-39) and CXCR6-R (59-AAAGTCAAGCCCCAAGGTG-39) for the cytoplasmic tail of red-capped mangabey CXCR6; and CCR2b2-Left (59-CTGGTTTGCTGGGGAAGATA-39) and CCR2b2-Right (59-GCTG-CATGCACATAGGCTAA-39) for the cytoplasmic tail region of redcapped mangabey CCR2B. The obtained PCR products were purified by gel extraction and introduced to the TOPO vector using a TOPO TA cloning kit (Life Technologies). Inserted fragments were sequenced by using a BigDye Terminator version 3.1 cycle sequencing kit (Applied Biosystems). Sequencing PCR was performed by using an ABI Prism 3130xl genetic analyser (Applied Biosystems) and data were analysed by Sequencher version 5.1 software (Gene Codes).
Phylogenetic analyses. The amino acid sequences of HIV-1 and SIV Nef proteins were aligned using CLUSTAL W implemented in MEGA5 (Tamura et al., 2011) . The following sequences were used (GenBank accession numbers in parentheses): HIV-1 strain NL4-3 (M19921), HIV-1 strain JRCSF (M38429), SIVcpz strain MB897 (JN835461), SIVcpz strain EK505 (JN835460), SIVrcm strain 02CM8081 (HM803689), SIVrcm strain GAB1 (AF382829), SIVrcm strain NG411 (AF349680), SIVgsn strain 99CM71 (AF468658), SIVgsn strain 99CM166 (AF468659), SIVmon strain NG1 (GQ925927), SIVmon strain 99CMCML1 (AY340701), SIVmus strain 01CM1085 (AY340700) and SIVmus strain 01CM1239 (EF070330). The phylogenetic tree of HIV-1/SIV Nef was reconstructed using the neighbour-joining method (Saitou & Nei, 1987) with MEGA5.
Plasmid construction. The ORFs of human CCR2B and CXCR6 were obtained by reverse transcription-PCR using cDNA derived from human PBMCs as the template, PrimeSTAR GXL DNA polymerase (TaKaRa) and the following primers: CCR2B-fwd, 59-TTTTTTTTTT-GGTACCGCCACCATGCTGTCCACATCTCGTTC-39; CCR2B-rev, 59-TATATATATAAAGCTTTTATAAACCAGCCGAGACTTCC-39; CXCR6-fwd, 59-TTTTTTTTTTGGTACCGCCACCATGGCAGAGCA-TGATTACCATG-39; and CXCR6-rev, 59-TATATATATAAAGCTTCT-ATAACTGGAACATGCTGGTG-39. The obtained DNA fragments were digested with Kpn I and HindIII, and then inserted into the Kpn I/HindIII site of pCMV-SPORT6 (Life Technologies). The expression plasmids for human CD4 and human CCR5 (based on pCMV-SPORT6) were as used in our previous studies (Sato et al., 2012; Yoshida et al., 2008) . The expression plasmids for the CD4 chimpanzee/red-capped mangabey cytoplasmic tail, CCR5 red-capped mangabey cytoplasmic tail and chimpanzee CCR2B cytoplasmic tail were constructed by using a GeneArt site-directed mutagenesis system (Life Technologies) and the following primers: CD4-CPZ/RCM-fwd, 59-GAAGGCGCCAAGCACAG-CGGATGTCTCAGA-39; 59-TCTGAGACATCCGCTGTGCTTGGCG-CCTTC-39; CD4-CPZ/RCM-rev, CCR5-RCM-fwd, 59-TTCCAGCAA-GACGCTTCCGAGCGAGCAAGCTCA-39; CCR5-RCM-rev, 59-TGA-GCTTGCTCGCTCGGAAGCGTCTTGCTGGAA-39; CPZ-CCR2B-fwd, 59-TCTACAGGGAGACAGCGGATGGAGTGACTTC-39; and CPZ-CCR2B-rev, 59-GAAGTCACTCCATCCGCTGTCTCCCTGTAGA-39. The expression plasmid for the cytoplasmic tail of red-capped mangabey CCR2B was constructed by overlap extension PCR using human CCR2B expression plasmid as the template, PrimeSTAR GXL DNA Polymerase (TaKaRa), and the following primers: 59-TCATCTATGCCTTCGTTG-GGGAGAAGTTCAGAAGGTATCT-39, 59-AGATACCTTCTGAACTT-CTCCCCAACGAAGGCATAGATGA-39, 59-ATCATCTATGCCTTCG-TTGGTGAGAAGTTCAGAAGGTATC-39 and 59-G ATACCTTCTGA-ACTTCTCACCAACGAAGGCATAGATGAT-39; CCR2B-fwd and CCR2B-rev (described above). The obtained DNA fragments were digested with Kpn I and HindIII, and then inserted into the Kpn I/HindIII site of pCMV-SPORT6 (Life Technologies). The sequences of the constructed plasmids were analysed as described above.
Cell culture and transfection. HEK-293T cells were maintained in Dulbecco's modified Eagle medium (Sigma) containing FCS (Sigma) and antibiotics (Life Technologies). Transfection was performed by using PEI Max (GE Healthcare) according to the manufacturer's procedure. The plasmids expressing CD4 (human cytoplasmic tail, 50 ng; chimpanzee/red-capped mangabey cytoplasmic tail, 150 ng), CCR5 (human cytoplasmic tail, 50 ng; red-capped mangabey cytoplasmic tail, 50 ng), CCR2B (human cytoplasmic tail, 100 ng; chimpanzee cytoplasmic tail, 50 ng; red-capped mangabey cytoplasmic tail, 50 ng) or CXCR6 (200 ng) were co-transfected with or without the plasmids (pCGCG-IRES-EGFP; 100 ng) expressing haemagglutinin (HA)-tagged Nefs of HIV-1 or SIV into HEK-293T cells. The amount of plasmid DNA was normalized to 2 mg using empty plasmid. At 48 h post-transfection, the cells were harvested, and used for Western blotting and flow cytometry as described below.
SDS-PAGE/Western blotting. SDS-PAGE/Western blotting was performed as described previously (Kobayashi et al., 2011 Sato et al., 2008 Sato et al., , 2009 ) by using the following antibodies: anti-HA antibody (3F10; Roche), anti-GFP antibody (GSN24; Sigma) and anti-a-tubulin (TUBA) antibody (DM1A; Sigma).
Flow cytometry. Flow cytometry was performed with a FACSCalibur (BD Biosciences) as described previously (Sato et al., 2012 (Sato et al., , 2013 and the obtained data were analysed with CellQuest software (BD Biosciences). For this analysis, the following antibodies conjugated with allophycocyanin were used: anti-human CD4 antibody (RPA-T4; BioLegend); anti-human CCR5 antibody (HEK/1/185a; BioLegend); anti-CCR2B antibody (K036C2; BioLegend) and anti-CXCR6 antibody (TG3/CXCR6; BioLegend). To analyse the extent of Nef-mediated downregulation of surface CD4 and coreceptors, GFPpositive cells (i.e. transfected cells) were gated and then the mean fluorescent intensity of each receptor was measured.
Statistical analyses. The data were expressed as mean+SD and significant differences (Pv0.05) were determined by Student's t-test.
